Gb3 mimetics (ViroCarb)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameGb3 mimetics (ViroCarb)
Drug Alias NameGb3 mimetic HIV entry inhibitors (ViroCarb)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHIV uptake inhibitors
TargetsUpdating
Therapy Area/IndicationsVesicular stomatitis virus infectionHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesViroCarb Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesViroCarb Inc
Active IndicationsN/A
Inactive IndicationsVesicular stomatitis virus infectionHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A